Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TIL stock hub

Instil Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TILis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
55.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
TIL
In the news

Latest news · TIL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-50.4
P25 -105.6P50 -46.5P75 -3.1
ROIC-14.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TIL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
179
Groups with data
11
Currency
USD
Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001789769
Company name
Instil Bio, Inc.
Country
United States
Country code
US
Cusip
45783C101
Employees
14
Employees Change
-35%
Employees Change Percent
-71.43
Enterprise value
$64.4M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2021-03-19
Isin
US45783C2008
Last refreshed
2026-05-10
Market cap
$55.3M
Market cap category
Micro-Cap
Price
$8.16
Price currency
USD
Sector
Healthcare
Sic
2836
Symbol
TIL
Website
https://instilbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-128.97%
FCF yield
-66.17%
P/B ratio
0.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
$-71.4M
Net Income Growth Quarters
2%
Net Income Growth Years
3%
Profit Per Employee
$-5.1M
ROA
-14.16
Roa5y
-17.08
ROCE
-26.63
ROE
-50.39
Roe5y
-45.29
ROIC
-14.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
-34%
Cagr3y
-14.46%
Cagr5y
-53.6%
EPS Growth Quarters
2
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$203.5M
Cash
$76.1M
Current Assets
$191.4M
Current Liabilities
$4.8M
Debt
$85.2M
Debt Equity
$0.75
Equity
$113.9M
Interest Coverage
-9.08
Liabilities
$89.7M
Long Term Assets
$12.1M
Long Term Liabilities
$84.8M
Net Cash
$-9M
Net Cash By Market Cap
$-16.35
Net Debt Equity
$0.08
Tangible Book Value
$113.9M
Tangible Book Value Per Share
$16.79
WACC
9.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
39.53
Net Working Capital
$110.8M
Quick ratio
15.89
Working Capital
$186.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-2.43%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-33.98%
200-day SMA
14.39
3Y total return
-37.42%
50-day SMA
8.37
50-day SMA vs 200-day SMA
50under200
5Y total return
-97.85%
All Time High
589.8
All Time High Change
-98.62%
All Time High Date
2021-03-22
All Time Low
5.67
All Time Low Change
43.92%
All Time Low Date
2026-01-06
ATR
0.46
Beta
1.95
Beta1y
1.05
Beta2y
5
Ch YTD
-25.82
High
8.2
High52
42.79
High52 Date
2025-06-10
High52ch
-80.93%
Low
8.08
Low52
5.67
Low52 Date
2026-01-06
Low52ch
43.92%
Ma50ch
-2.54%
Price vs 200-day SMA
-43.29%
RSI
49.24
RSI Monthly
36.61
RSI Weekly
38.7
Sharpe ratio
0.19x
Sortino ratio
0.32
Total Return
-2.43%
Tr YTD
-25.82
Tr1m
-3.43%
Tr1w
3.29%
Tr3m
5.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

8
MetricValue
Analyst Count
3
Analyst Count Top
1
Analyst Ratings
Buy
Analyst Ratings Top
Hold
Earnings EPS Estimate
$-0.6
Operating Income
$-52.9M
Price target
$125
Price Target Change
$1,432

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
3,210,535%
Float Percent
47.34%
Shares Insiders
9.08%
Shares Institutions
21.36%
Shares Out
6,781,976
Shares Qo Q
0.36%
Shares Yo Y
2.43%
Short Float
10.23%
Short Ratio
11.08
Short Shares
4.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$-45.3M
Average Volume
24,866.15x
Bv Per Share
16.79
Ch1m
-3.43
Ch1w
3.29
Ch1y
-33.98
Ch3m
5.16
Ch3y
-37.42
Ch5y
-97.85
Ch6m
-45.92
Change
1.62%
Change From Open
0.74
Close
8.03
Days Gap
0.87
Depreciation Amortization
534,000
Dollar Volume
133,791.4
Earnings Date
2026-05-22
Earnings Time
bmo
EBIT
$-52.9M
EBITDA
$-52.4M
EPS
$-10.7
F Score
2
FCF
$-36.6M
FCF EV Yield
-56.87x
FCF Per Share
$-5.4
Financing CF
7,292,000
Fiscal Year End
December
Founded
2,018
Investing CF
25,476,000
Ipr
-59.2
Iprfo
-98.49
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-27
Last Report Date
2025-12-31
Last Split Date
2023-12-08
Last Split Type
Reverse
Last10k Filing Date
2026-03-27
Ma150
10.85
Ma150ch
-24.8%
Ma20
8.23
Ma20ch
-0.86%
Net CF
-3,831,000
Next Earnings Date
2026-05-22
Open
8.1
Optionable
No
Position In Range
66.67
Post Close
8.16
Postmarket Change Percent
-0.74
Postmarket Price
$8.1
Ppne
364,000
Price Date
2026-05-08
Ptbv Ratio
0.49
Relative Volume
0.66x
Share Based Comp
8,693,000
Tr6m
-45.92%
Us State
Texas
Volume
16,396
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TIL pay a dividend?

Capital-return profile for this ticker.

Performance

TIL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.0%
S&P 500 1Y: n/a
3Y total return
-37.4%
S&P 500 3Y: n/a
5Y total return
-97.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TIL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+21.4%
Float: +47.3% of shares outstanding
Insider ownership
+9.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+10.2%
11.1 days to cover
Y/Y dilution
+2.4%
Negative means the company is buying back shares.
Technical

TIL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.2
Neutral momentum band
Price vs 200-day MA
-43.3%
50/200-day relationship not available
Beta (5Y)
1.95
More volatile than the market
Sharpe ratio
0.19
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TIL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TIL stock rating?

Instil Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TIL analysis?

The full report lives at /stocks/TIL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TIL?

The latest report frames TIL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TIL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.